Relmada Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $872k | 211k | 4.14 |
| 2023-09-30 | $641k | 214k | 3.00 |
| 2023-06-30 | $583k | 237k | 2.46 |
| 2023-03-31 | $84k | 37k | 2.26 |
| 2022-12-31 | $58k | 17k | 3.49 |
| 2022-06-30 | $167k | 8.8k | 18.95 |
| 2021-12-31 | $235k | 10k | 22.58 |
| 2021-06-30 | $199k | 6.2k | 32.05 |
| 2021-03-31 | $274k | 7.8k | 35.25 |
| 2020-12-31 | $187k | 5.8k | 32.12 |
| 2020-09-30 | $284k | 7.6k | 37.57 |
| 2020-06-30 | $394k | 8.8k | 44.74 |
| 2020-03-31 | $476k | 14k | 34.09 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation